Oct 18 PExA AB :
* The European Commission has selected PExAs project "BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets" for funding through the Research and Innovation Framework Program Horizon 2020
* Each project receives 50,000 euros ($54,940.00) to carry out a feasibility study and to prepare a Phase 2 program which, if granted, could result in significant additional funding
* A Phase 2 program, could be financed up to 2.5 million euros by the European Commission
* The feasibility study is expected to be completed during H1 2017 Source text: bit.ly/2eBpBjA
Further company coverage:
($1 = 0.9101 euros) (Gdynia Newsroom)
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.
UPDATE 2-Trump moves to quickly fill his top Cabinet ranks
NEW YORK, Dec 2 U.S. President-elect Donald Trump said he expected to have most members of his Cabinet announced next week, interviewing more candidates at Trump Tower for top jobs in his administration as he prepares to take office on Jan. 20.